These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22763308)

  • 21. Repeated sugammadex usage in a patient with multiple sclerosis: a case report.
    Sinikoglu N; Totoz T; Gumus F; Karagulle O
    Wien Klin Wochenschr; 2016 Jan; 128(1-2):71-3. PubMed ID: 25586446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Neostigmine-resistant curarization".
    Baraka A
    Middle East J Anaesthesiol; 2013 Jun; 22(2):131-4. PubMed ID: 24180159
    [No Abstract]   [Full Text] [Related]  

  • 23. Do we really need sugammadex as an antagonist of muscle relaxants in anesthesia?
    Meistelman C; Donati F
    Curr Opin Anaesthesiol; 2016 Aug; 29(4):462-7. PubMed ID: 27168088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis.
    Weekes G; Hayes N; Bowen M
    Int J Obstet Anesth; 2010 Jul; 19(3):333-6. PubMed ID: 20627694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Monitoring of neuromuscular block and prevention of residual paralysis].
    Fuchs-Buder T; Meistelman C
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S46-50. PubMed ID: 19887277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No effect of intraoperative rocuronium doses on 30-day postoperative complications after sugammadex reversal in patients undergoing gastrointestinal surgery.
    Onoe K; Ogata H; Ishimoto D; Kaneko T; Ueki R; Kariya N; Tatara T; Hirose M
    J Clin Anesth; 2020 May; 61():109662. PubMed ID: 31759814
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sugammadex and profound rocuronium neuromuscular blockade induced by magnesium sulphate].
    Grandjean B; Guerci P; F Vial ; Raft J; Fuchs-Buder T; Bouaziz H
    Ann Fr Anesth Reanim; 2013 May; 32(5):378-9. PubMed ID: 23664923
    [No Abstract]   [Full Text] [Related]  

  • 28. Laryngeal stridor as a sign of residual curarization.
    Boliston TA
    Br J Anaesth; 1971 Oct; 43(10):931. PubMed ID: 4255960
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
    de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
    Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
    Ammar AS; Mahmoud KM; Kasemy ZA
    Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The incidence of postoperative residual curarization in the recovery room after rocuronium administration].
    Adamus M; Koutná J; Neoral C
    Rozhl Chir; 2007 Jan; 86(1):11-6. PubMed ID: 17416073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
    Barrio J; San Miguel G; García V; Pelegrín F
    Rev Esp Anestesiol Reanim; 2007; 54(7):399-404. PubMed ID: 17953333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial.
    Putz L; Dransart C; Jamart J; Marotta ML; Delnooz G; Dubois PE
    J Clin Anesth; 2016 Dec; 35():107-113. PubMed ID: 27871505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium.
    Patel N; Kamath N; Smith CE; Pinchak AC; Hagen JH
    Can J Anaesth; 1997 Jan; 44(1):49-53. PubMed ID: 8988824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of a 'reversed' isolated forearm technique by regional antagonization of rocuronium-induced neuromuscular block: a pilot study.
    Hamp T; Mairweck M; Schiefer J; Krammel M; Pablik E; Wolzt M; Plöchl W
    Br J Anaesth; 2016 Jun; 116(6):797-803. PubMed ID: 26934944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residual neuromuscular block in type II diabetes mellitus after rocuronium: a prospective observational study.
    Armendáriz-Buil I; Lobato-Solores F; Aguilera-Celorrio L; Morros-Díaz E; Fraile-Jiménez E; Vera-Bella J
    Eur J Anaesthesiol; 2014 Aug; 31(8):411-6. PubMed ID: 24201596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On extubation, residual curarization, and their circumstances].
    Ortiz-Gómez JR; Fabregat-López J
    Rev Esp Anestesiol Reanim; 2009; 56(6):335-8. PubMed ID: 19725339
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacology of sugammadex].
    Meistelman C; Fuchs-Buder T
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S51-6. PubMed ID: 19887278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case scenario: residual curarization in diabetic polyneuropathy.
    Unterbuchner C; Fink H; Berthele A; Blobner M
    Anesthesiology; 2014 Feb; 120(2):474-9. PubMed ID: 24051390
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-lasting potentiation of a single-dose of rocuronium by amikacin: case report.
    Gilliard V; Delvaux B; Russell K; Dubois PE
    Acta Anaesthesiol Belg; 2006; 57(2):157-9. PubMed ID: 16916186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.